Western Oncolytics develops novel therapies for cancer. We take cutting-edge treatments that show promise in early laboratory research and demonstrate their value to patients in clinical trials. We expect that our lead technology, a novel immuno-oncolytic therapy, can extend the lives of, or outright cure, patients across a wide range of cancer types, while avoiding the severe side effects common with current cancer therapies. Thus, we aim to use the most sophisticated science to give life and hope to cancer patients.